News

Pfizer's Hympavzi meets key phase III goals, demonstrating a significant reduction in bleeding in hemophilia patients with ...
UK-based celebrity nutritionist Rose Ferguson previously revealed an uptick in the her clients who are worried about facial ...
Announcing a new publication for Acta Materia Medica journal. The prevalence of diabetes is increasing and expected to become ...
Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.
A team of researchers at Rowan University has developed a groundbreaking injectable biomaterial that could significantly improve recovery outcomes following spinal cord injuries. The study, recently ...